NCT06606262

Brief Summary

Background: recurrent acute tonsillitis (RT) is a frequent condition affecting teenagers and adults. Patients suffer from recurring throat symptoms, fever and impaired quality of life (QOL). Tonsillectomy (TE) is the only well-known treatment, but studies indicate that tonsillotomy (TO) is associated with less morbidity (eg. pain and bleeding) and equal efficiency (e.g. reduced number of sore throat episodes and improved QOL). The investigator aim to clarify whether TO is a non-inferior alternative to TE. Methods: inclusion and randomization of 250 adult RT patients for TE or TO with a 12 month follow up. Comparisons will be made between groups, and outcome measures includes number of sore throat episodes, QOL and postoperative pain. Discussion: the study has the potential to improve the treatment of a prevalent disease by enhancing knowledge of an alternative procedure (TO) associated with less discomfort and risk than the current standard procedure (TE) and a presumably low risk of insufficiency.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
45mo left

Started Oct 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Oct 2024Dec 2029

First Submitted

Initial submission to the registry

August 26, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

September 20, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

October 31, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

December 19, 2024

Status Verified

December 1, 2024

Enrollment Period

2.1 years

First QC Date

August 26, 2024

Last Update Submit

December 17, 2024

Conditions

Keywords

tonsillectomytonsillotomyquality of life

Outcome Measures

Primary Outcomes (4)

  • Number of sore throat episodes after TE vs. TO.

    12 months (and 24, 36 and 60 months)

  • QOL measured as postoperative Tonsillectomy Outcome Inventory 14 (TOI-14) score after TE vs. TO

    A disease-specific questionnaire for adults with tonsillitis. It is used pre- and postoperatively to detect changes in quality of life. It consists of 14 questions that covers four subscales: throat dis-comfort (question 1-4) general health (question 5-6), resources (question 7-10), and social psychological restrictions (question 11-14). The questionnaire uses a six-point Likert scale with 0 representing "no problem" and 5 representing "couldn't be worse". The points are summed, divided by the number of questions multiplied by 5, and multiplied by 100, giving scores in the range 0-100, where higher scores reflect poorer quality of life

    12 months (and 24, 36 and 60 months)

  • Summarized postoperative pain scores (days 1-10)

    Measured on a numeric rating scale from 0 til 10 in which 0 represents "no pain" and 10 represents "excruciating pain"

    Days 1-10

  • Overall postoperative discomfort (day 21)

    Measured on a numeric rating scale from 0 til 10 in which 0 represents "no discomfort" and 10 represents "excruciating discomfort"

    Day 21

Secondary Outcomes (5)

  • Proportion of patients cured (defined as postoperative TOI-14<15) after TE vs. TO

    12 months (and 24, 36 and 60 months)

  • Overall patient satisfaction after TE vs. TO

    12 months (and 24, 36 and 60 months)

  • Postoperative Glasgow Benefit Inventory (GBI) score after TE vs. TO

    12 months (and 24, 36 and 60 months)

  • Number of sore throat days after TE vs. TO

    12 months (and 24, 36 and 60 months)

  • Prevalence of reoperation after TE vs. TO

    12 months (and 24, 36 and 60 months)

Study Arms (2)

Tonsillotomy

EXPERIMENTAL

A potential non-inferior surgical procedure for treating recurrent acute tonsillitis.

Procedure: Tonsillotomy

Tonsillectomy

ACTIVE COMPARATOR

The current standard surgical procedure for treating recurrent acute tonsillitis.

Procedure: Tonsillectomy

Interventions

TonsillotomyPROCEDURE

Bilateral partial removal of the palatine tonsils to a level between the pharyngeal pillars and the tonsillar capsule. Surgery will be performed under general anesthesia using monopolar electrocautery.

Also known as: Intracapsular tonsillectomy, TO
Tonsillotomy
TonsillectomyPROCEDURE

Bilateral extracapsular removal of palatine tonsils. Surgery will be performed under general anesthesia using "cold knife" dissection.

Also known as: Extracapsular tonsillectomy, TE
Tonsillectomy

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (age ≥15 years) with RT, defined as a minimum of five tonsillitis episodes in one year or a minimum of three tonsillitis episodes per year for two years (Danish National Guidelines criteria
  • The ability to understand Danish orally and in writing.

You may not qualify if:

  • Previous TE or TO.
  • Suspected tonsillar malignancy.
  • History of malignant tumor in the oral cavity, the pharynx or the larynx.
  • Previous radiation therapy on head or neck.
  • Hemorrhagic diathesis or anticoagulant therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Aalborg University Hospital

Aalborg, 9000, Denmark

RECRUITING

Aarhus University Hospital

Aarhus, 8200, Denmark

RECRUITING

MeSH Terms

Interventions

Tonsillectomy

Intervention Hierarchy (Ancestors)

Otorhinolaryngologic Surgical ProceduresSurgical Procedures, Operative

Central Study Contacts

Hannah Inez Houborg, MD

CONTACT

Tejs Ehlers Klug, MD, DMSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, DMSc, Clinical Associate Professor

Study Record Dates

First Submitted

August 26, 2024

First Posted

September 20, 2024

Study Start

October 31, 2024

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 31, 2029

Last Updated

December 19, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations